COMP <GO>
XTNT vs NEPH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Xtant Medical Holdings Inc. (NYSE) VS. Nephros Inc. (NASDAQ) • 15-METRIC TALLY: XTNT 5
— NEPH 5
■ METRIC PARITY
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
options-implied-move
—
LAST: $3.27 (+3.16%) • MKT CAP: $35.5M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XTNT VS. NEPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XTNT | NEPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.90% | 61.90% | +1.00 | XTNT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.80% | 18.90% | -6.10 | NEPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.7x | 26.3x | -22.60 | XTNT | /valuation <GO> |
| Free Cash Flow Yield | 24.95% | 4.50% | +20.45 | XTNT | /fcf-yield <GO> |
| Operating Margin | 5.40% | 6.10% | -0.70 | NEPH | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 6.40% | -6.40 | NEPH | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | 32.70% | -18.50 | NEPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.9 | 36.7 | -1.74 | NEPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 25.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.7M | $35.5M | $5.2M | XTNT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XTNT REV | NEPH REV | XTNT GROSS % | NEPH GROSS % | XTNT FCF | NEPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $133.9M | $18.8M | 62.9% | 61.9% | $10.2M | $1.6M |
| FY 2024 | $117.3M | $14.2M | 58.2% | 61.6% | -$16.0M | -$547.0K |
| FY 2023 | $91.3M | $14.2M | — | — | -$9.5M | $827.0K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XTNT // BETA —
NEPH // BETA —